Aurora Cannabis (NYSE:ACB) and Tauriga Sciences (OTCMKTS:TAUG) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, dividends, analyst recommendations and profitability.
This is a breakdown of current recommendations for Aurora Cannabis and Tauriga Sciences, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Aurora Cannabis presently has a consensus target price of $8.72, indicating a potential upside of 27.45%. Given Aurora Cannabis’ higher probable upside, equities research analysts plainly believe Aurora Cannabis is more favorable than Tauriga Sciences.
This table compares Aurora Cannabis and Tauriga Sciences’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Risk and Volatility
Aurora Cannabis has a beta of 2.49, indicating that its share price is 149% more volatile than the S&P 500. Comparatively, Tauriga Sciences has a beta of 1.77, indicating that its share price is 77% more volatile than the S&P 500.
Earnings & Valuation
This table compares Aurora Cannabis and Tauriga Sciences’ top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Aurora Cannabis||$43.49 million||159.50||$56.66 million||$0.12||57.00|
|Tauriga Sciences||$60,000.00||60.78||-$1.10 million||N/A||N/A|
Aurora Cannabis has higher revenue and earnings than Tauriga Sciences.
Insider & Institutional Ownership
9.0% of Aurora Cannabis shares are owned by institutional investors. 6.2% of Tauriga Sciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Aurora Cannabis beats Tauriga Sciences on 9 of the 11 factors compared between the two stocks.
About Aurora Cannabis
Aurora Cannabis Inc. produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company's products consist of dried cannabis and cannabis oil; CanniMed vegan capsules; and hemp products, as well as sells vaporizers, consumable vaporizer accessories, and herb mills for using herbal cannabis products. It also operates CanvasRX, a network of cannabis counseling and outreach centers; and provides cannabis analytical product testing services. As of February 26, 2019, the company had operations in 24 countries across five continents. Aurora Cannabis Inc. has collaboration agreements with PharmaChoice, Pharmasave, and Shoppers Drug Mart for the distribution, sale, and marketing of medical cannabis products through their respective networks of pharmacies. The company has a strategic agreements with Hempco Food and Fiber Inc.; CTT Pharmaceuticals Inc.; Choom Holdings Inc.; Capcium Inc.; The Green Organic Dutchman Holdings Ltd.; Société des Alcools du Québec; Alcanna; Radient Technologies; Micron Waste; Wagner Dimas; Evio; and Cann Group Limited. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
About Tauriga Sciences
Tauriga Sciences, Inc. produces, licenses, and sells lip balm products under the HerMan brand name. The company was founded in 2001 and is based in New York, New York.
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.